Moxetumomab
Product Specifications
CAS Number
1622075-65-3
Target
Immunology/Inflammation related, ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related, Immunology/Inflammation
Purity
0.978
Bioactivity
Moxetumomab is a monoclonal antibody targeting CD22, which can be used to synthesise the antibody-drug conjugate (ADC) Moxetumomab pasudotox for the study of hairy cell leukaemia (HCL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1394572-01 0.02 mg (E-Coli)
Recombinant Shewanella oneidensis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1394572-02 0.02 mg (Yeast)
Recombinant Shewanella oneidensis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1394572-03 0.1 mg (E-Coli)
Recombinant Shewanella oneidensis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details MBS1394572-04 0.1 mg (Yeast)
Recombinant Shewanella oneidensis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA)
Sign In for Pricing
View Details